THE EFFECT OF FLT3 LIGAND ON PRIMARY ACUTE HUMAN LEUKEMIAS

被引：0

作者：

MCKENNA, HJ

SMITH, FO

DEVRIES, P

BRASEL, K

LYMAN, SD

WILLIAMS, DE

机构：

[1] INDIANA UNIV,SCH MED,INDIANAPOLIS,IN 46202

[2] CHILDRENS CANC GRP,ARCADIA,CA

[3] IMMUNEX CORP,SEATTLE,WA

来源：

BLOOD | 1994年 / 84卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：A52 / A52

页数：1

共 50 条

[41] Effect of Flt3 ligand gene transfer in experimental pancreatic cancer [J].

Ryschich, E. ;

Huszty, G. ;

Wentzensen, N. ;

Schmidt, E. ;

Knaebel, H. P. ;

Encke, J. ;

Maerten, A. ;

Buechler, M. W. ;

Schmidt, J. .

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2007, 22 (02) :215-223

[42] THE LIGAND FOR FLT3/FLK2 [J].

HANNUM, C ;

CULPEPPER, J ;

CAMPBELL, D ;

MCCLANAHAN, T ;

DUDA, G ;

ZURAWSKI, S ;

RENNICK, D ;

WAGNER, J ;

MARTINA, N ;

KASTELEIN, R ;

SHANAFELT, A ;

PETERSON, D ;

MENON, S ;

DANG, W ;

MATTSON, J ;

LUH, J ;

BAZAN, F ;

ROSNET, O ;

DUBREUIL, P ;

BIRNBAUM, D ;

LEE, F .

JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, :19-19

[43] FLT3 ligand in acute myeloid leukemia: a simple test with deep implications [J].

Peterlin, Pierre ;

Chevallier, Patrice ;

Knapper, Steven ;

Collin, Matthew .

LEUKEMIA & LYMPHOMA, 2021, 62 (02) :264-270

[44] FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells [J].

Zheng, R ;

Levis, M ;

Piloto, O ;

Brown, P ;

Baldwin, BR ;

Gorin, NC ;

Beran, M ;

Zhu, ZP ;

Ludwig, D ;

Hicklin, D ;

Witte, L ;

Li, YW ;

Small, D .

BLOOD, 2003, 102 (11) :589A-589A

[45] FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells [J].

Zheng, R ;

Levis, M ;

Piloto, O ;

Brown, P ;

Baldwin, BR ;

Gorin, NC ;

Beran, M ;

Zhu, ZP ;

Ludwig, D ;

Hicklin, D ;

Witte, L ;

Li, YW ;

Small, D .

BLOOD, 2004, 103 (01) :267-274

[46] Synergistic Effect of SGN-CD33A and FLT3 Inhibitors in FLT3/ITD Acute Myeloid Leukemia [J].

Tarlock, Katherine ;

Thurman, Robert ;

Rohm, Rory ;

Biechele, Travis ;

Arthur, Bill ;

Meshinchi, Soheil .

BLOOD, 2018, 132

[47] FLT3 Mutation in Acute Myeloid Leukemia: Primary or Secondary Mutation? [J].

Ma, Wanlong ;

De Dios, Ivan ;

Funari, Vincent ;

Sudarsanam, Sucha ;

Jiang, Shi-Ping ;

Agersborg, Sally ;

Hummel, Jennifer ;

Blocker, Forrest ;

Albitar, Maher .

BLOOD, 2017, 130

[48] Expression of a recombinant FLT3 ligand and its emtansine conjugate as a therapeutic candidate against acute myeloid leukemia cells with FLT3 expression [J].

Zhang, Dengyang ;

Guo, Yao ;

Zhao, Yuming ;

Yu, Liuting ;

Chang, Zhiguang ;

Pei, Hanzhong ;

Huang, Junbin ;

Chen, Chun ;

Xue, Hongman ;

Xu, Xiaojun ;

Pan, Yihang ;

Li, Ningning ;

Zhu, Chengming ;

Zhao, Zhizhuang Joe ;

Yu, Jian ;

Chen, Yun .

MICROBIAL CELL FACTORIES, 2021, 20 (01)

[49] OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia [J].

Bartholomew J. Eisfelder ;

Caner Saygin ;

Joseph Wynne ;

Margaret W. Colton ;

Mariafausta Fischietti ;

Elspeth M. Beauchamp ;

Jason X. Cheng ;

Olatoyosi Odenike ;

Gail Roboz ;

Houda Alachkar ;

Wendy Stock .

Blood Cancer Journal, 11

[50] OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia [J].

Eisfelder, Bartholomew J. ;

Saygin, Caner ;

Wynne, Joseph ;

Colton, Margaret W. ;

Fischietti, Mariafausta ;

Beauchamp, Elspeth M. ;

Cheng, Jason X. ;

Odenike, Olatoyosi ;

Roboz, Gail ;

Alachkar, Houda ;

Stock, Wendy .

BLOOD CANCER JOURNAL, 2021, 11 (03)

← 1 2 3 4 5 →